PROSHARES TR - PSHS SH MSCI EMR (EUM) Institutional Ownership

CUSIP: 74347R396

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2024

Type / Class
Equity / PSHS SH MSCI EMR
Symbol
EUM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 74347R396?
CUSIP 74347R396 identifies EUM - PROSHARES TR - PSHS SH MSCI EMR in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of PROSHARES TR - PSHS SH MSCI EMR (EUM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$523,776 0
2024 Q3 41,940 $523,776 -$1,371,235 $12.49 8
2024 Q2 141,240 $1,896,389 +$148,844 $13.43 7
2024 Q1 125,570 $1,752,962 -$801,530 $13.96 10
2023 Q4 464,081 $6,565,848 -$387,062 $14.15 13
2023 Q3 483,301 $7,423,625 +$1,019,306 $15.34 14
2023 Q2 429,852 $6,290,833 -$4,096,551 $14.63 16
2023 Q1 710,660 $10,467,782 -$2,306,660 $14.74 19
2022 Q4 854,802 $13,053,610 -$16,220,270 $15.28 21
2022 Q3 1,688,968 $28,548,305 +$9,620,861 $16.96 24
2022 Q2 1,291,340 $19,109,000 +$4,251,246 $14.80 21
2022 Q1 1,008,062 $13,610,000 -$208,281 $13.50 14
2021 Q4 1,032,619 $13,130,275 -$14,604,659 $12.72 15
2021 Q3 2,182,732 $27,597,000 +$24,979,189 $12.66 16
2021 Q2 211,877 $2,483,000 -$584,753 $11.72 12
2021 Q1 257,575 $3,160,000 +$792,347 $12.27 13
2020 Q4 189,729 $2,444,000 -$18,056,685 $12.89 11
2020 Q3 1,449,665 $22,381,000 +$2,516,629 $15.44 16
2020 Q2 1,268,715 $21,870,000 +$4,241,106 $17.23 19
2020 Q1 1,012,822 $21,136,000 +$1,737,946 $20.87 18
2019 Q4 963,224 $16,421,000 -$10,992,314 $17.06 22
2019 Q3 1,589,186 $30,379,000 +$2,910,701 $19.14 25
2019 Q2 1,449,735 $26,509,000 +$4,742,160 $18.28 22
2019 Q1 1,206,451 $22,275,000 -$8,150,061 $18.49 22
2018 Q4 1,641,326 $33,436,000 -$9,444,928 $20.39 20
2018 Q3 1,968,562 $37,681,000 +$8,577,786 $19.14 24
2018 Q2 1,520,541 $28,957,000 +$13,460,731 $19.05 20
2018 Q1 835,254 $14,474,000 +$6,087,620 $17.30 19
2017 Q4 521,882 $9,253,000 -$7,331,034 $17.95 17
2017 Q3 895,759 $17,133,000 +$153,518 $19.20 17
2017 Q2 864,158 $17,959,368 -$2,822,166 $20.83 16
2017 Q1 991,333 $21,894,000 -$16,267,110 $22.09 15
2016 Q4 1,677,226 $41,692,000 +$3,657,483 $24.96 20
2016 Q3 1,493,365 $35,674,000 -$23,717,967 $23.85 17
2016 Q2 2,428,004 $63,940,000 -$8,235,100 $26.29 27
2016 Q1 2,708,437 $73,645,624 -$87,722,396 $27.08 33
2015 Q4 5,653,694 $166,583,000 -$103,803,316 $29.46 38
2015 Q3 9,145,323 $273,115,948 +$24,439,371 $29.88 42
2015 Q2 8,266,981 $209,753,000 +$57,383,079 $25.36 22
2015 Q1 5,981,691 $154,104,000 +$115,556,864 $25.46 22
2014 Q4 1,394,896 $36,727,000 -$35,327,009 $26.33 19
2014 Q3 2,885,803 $73,590,598 +$34,923,702 $25.49 21
2014 Q2 1,514,198 $37,434,000 -$92,670,500 $24.73 22
2014 Q1 5,065,654 $133,950,902 +$98,604,179 $26.45 28